Plant Molecular Farming: Much More than Medicines

Annual Review of Analytical Chemistry

Volumn 9, Issue , 2016, Pages 271-294

  Tschofen, Marc ^a   Knopp, Dietmar ^b   Hood, Elizabeth ^c   Stöger, Eva ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c ARKANSAS STATE UNIVERSITY   (United States)

Author keywords

Biofuel; Papermaking; Plant biotechnology; Plant made proteins; Recombinant protein; Technical enzymes

Indexed keywords

BIOFUELS; DIAGNOSIS; INDUSTRIAL RESEARCH; PURIFICATION; RECOMBINANT PROTEINS;

DEVELOPMENT TIME; LOW-COSTS; MEDICAL PRODUCTS; MOLECULAR FARMING; PLANT BIOTECHNOLOGY; PLANT PRODUCTION; PLANT-MAKE PROTEIN; PRODUCT BENEFITS; PRODUCTION SYSTEM; TECHNICAL ENZYME;

ENZYMES;

BIOTECHNOLOGY; DRUGS; ENZYMES; PAPER MAKING; PROTEINS;

ANTIBODY; BIOLOGICAL PRODUCT; ENZYME; SIGNAL PEPTIDE;

BIOSYNTHESIS; METABOLISM; MOLECULAR FARMING; PLANT;

ANTIBODIES; BIOLOGICAL PRODUCTS; ENZYMES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR FARMING; PLANTS;

EID: 84975469462     PISSN: 19361327     EISSN: 19361335     Source Type: Book Series    
DOI: 10.1146/annurev-anchem-071015-041706     Document Type: Review

References (143)

1. Hiatt A, Cafferkey R, Bowdish K. 1989. Production of antibodies in transgenic plants. Nature 342:76-78
2. Sijmons PC, Dekker BM, Schrammeijer B, Verwoerd TC, van den Elzen PJ, Hoekema A. 1990. Production of correctly processed human serum albumin in transgenic plants. Biotechnology 8:217-21
3. Paul MJ, Teh AY, Twyman RM,Ma JK. 2013. Target product selection-Where can molecular pharming make the difference? Curr. Pharm. Des. 19:5478-85
4. Stöger E, Fischer R, Moloney M, Ma JK. 2014. Plant molecular pharming for the treatment of chronic and infectious diseases. Annu. Rev. Plant Biol. 65:743-68
5. Tekoah Y, Shulman A, Kizhner T, Ruderfer I, Fux L, et al. 2015. Large-scale production of pharmaceutical proteins in plant cell culture-The protalix experience. Plant Biotechnol. J. 13:1199-208
6. Hood E, Witcher D, Maddock S, Meyer T, Baszczynski C, et al. 1997. Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol. Breed. 3:291-306
7. Fischer R, Schillberg S, Buyel JF, Twyman RM. 2013. Commercial aspects of pharmaceutical protein production in plants. Curr. Pharm. Des. 19:5471-77
8. Kolotilin I, Topp E, Cox E, Devriendt B, Conrad U, et al. 2014. Plant-based solutions for veterinary immunotherapeutics and prophylactics. Vet. Res. 45:117
9. MacDonald J, Doshi K, Dussault M, Hall JC, Holbrook L, et al. 2015. Bringing plant-based veterinary vaccines to market: Managing regulatory and commercial hurdles. Biotechnol. Adv. 33(8):1572-81
10. Clarke JL, Waheed MT, Lossl AG, Martinussen I, Daniell H. 2013. How can plant genetic engineering contribute to cost-effective fish vaccine development for promoting sustainable aquaculture? Plant Mol. Biol. 83:33-40
11. Avesani L, Merlin M, Gecchele E, Capaldi S, Brozzetti A, et al. 2014. Comparative analysis of different biofactories for the production of a major diabetes autoantigen. Transgenic Res. 23:281-91
12. Merlin M, Gecchele E, Capaldi S, Pezzotti M, Avesani L. 2014. Comparative evaluation of recombinant protein production in different biofactories: The green perspective. Biomed. Res. Int. 2014:136419
13. Baeshen NA, BaeshenMN, Sheikh A, Bora RS, AhmedM, et al. 2014. Cell factories for insulin production. Microb. Cell Fact. 13:141
14. Ma JK,Hiatt A,HeinM, VineND, Wang F, et al. 1995. Generation and assembly of secretory antibodies in plants. Science 268:716-19
15. Loos A, Gruber C, Altmann F, Mehofer U, Hensel F, et al. 2014. Expression and glycoengineering of functionally active heteromultimeric IgM in plants. PNAS 111:6263-68
16. Hauptmann V, Weichert N, Rakhimova M, Conrad U. 2013. Spider silks from plants-A challenge to create native-sized spidroins. Biotechnol. J. 8:1183-92
17. Stein H, Wilensky M, Tsafrir Y, Rosenthal M, Amir R, et al. 2009. Production of bioactive, posttranslationally modified, heterotrimeric, human recombinant type-I collagen in transgenic tobacco. Biomacromolecules 10:2640-45
18. Komori R, Amano Y, Ogawa-Ohnishi M, Matsubayashi Y. 2009. Identification of tyrosylprotein sulfotransferase in Arabidopsis. PNAS 106:15067-72
19. Matsubayashi Y. 2011. Post-translational modifications in secreted peptide hormones in plants. Plant Cell Physiol. 52:5-13
20. GomordV, Fitchette AC,Menu-BouaouicheL, Saint-Jore-DupasC,PlassonC, et al. 2010. Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol. J. 8:564-87
21. Strasser R, Altmann F, Steinkellner H. 2014. Controlled glycosylation of plant-produced recombinant proteins. Curr. Opin. Biotechnol. 30:95-100
22. Cox KM, Sterling JD, Regan JT, Gasdaska JR, Frantz KK, et al. 2006. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotechnol. 24:1591-97
23. ForthalDN, Gach JS, Landucci G, Jez J, Strasser R, et al. 2010. Fc-glycosylation influences Fcgamma receptor binding and cell-mediated anti-HIV activity ofmonoclonal antibody 2G12. J. Immunol. 185:6876-82
24. Ullrich KK, Hiss M, Rensing SA. 2015. Means to optimize protein expression in transgenic plants. Curr. Opin. Biotechnol. 32:61-67
25. Twyman RM, Schillberg S, Fischer R. 2013. Optimizing the yield of recombinant pharmaceutical proteins in plants. Curr. Pharm. Des. 19:5486-94
26. Kirchhoff J, Raven N, Boes A, Roberts JL, Russell S, et al. 2012. Monoclonal tobacco cell lines with enhanced recombinant protein yields can be generated from heterogeneous cell suspension cultures by flow sorting. Plant Biotechnol. J. 10:936-44
27. Hood EE, Devaiah SP, Fake G, Egelkrout E, Teoh KT, et al. 2012. Manipulating corn germplasm to increase recombinant protein accumulation. Plant Biotechnol. J. 10:20-30
28. Rademacher T, Sack M, Arcalis E, Stadlmann J, Balzer S, et al. 2008. Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol. J. 6:189-201
29. Fischer R, VasilevN, Twyman RM, Schillberg S. 2015. High-value products from plants: The challenges of process optimization. Curr. Opin. Biotechnol. 32:156-62
30. Buyel JF. 2015. Process development strategies in plant molecular farming. Curr. Pharm. Biotechnol. 16:966-82
31. He Y, Ning T, Xie T, Qiu Q, Zhang L, et al. 2011. Large-scale production of functional human serum albumin from transgenic rice seeds. PNAS 108:19078-83
32. Devaiah SP, Requesens DV, Chang YK, Hood KR, Flory A, et al. 2013. Heterologous expression of cellobiohydrolase II (Cel6A) in maize endosperm. Transgenic Res. 22:477-88
33. De Jaeger G, Scheffer S, Jacobs A, Zambre M, Zobell O, et al. 2002. Boosting heterologous protein production in transgenic dicotyledonous seeds using Phaseolus vulgaris regulatory sequences. Nat. Biotechnol. 20:1265-68
34. OeyM, Lohse M, Kreikemeyer B, Bock R. 2009. Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J. 57:436-45
35. Twyman RM, Stöger E, Schillberg S, Christou P, Fischer R. 2003. Molecular farming in plants: host systems and expression technology. Trends Biotechnol. 21:570-78
36. Doran PM. 2006. Foreign protein degradation and instability in plants and plant tissue cultures. Trends Biotechnol. 24:426-32
37. Hofbauer A, Stöger E. 2013. Subcellular accumulation and modification of pharmaceutical proteins in different plant tissues. Curr. Pharm. Des. 19:5495-502
38. Martoglio B, Dobberstein B. 1998. Signal sequences: more than just greasy peptides. Trends Cell Biol. 8:410-15
39. Schouten A, Roosien J, van Engelen FA, de Jong GA, Borst-Vrenssen AW, et al. 1996. The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco. Plant Mol. Biol. 30:781-93
40. Neuhaus JM, Rogers JC. 1998. Sorting of proteins to vacuoles in plant cells. Plant Mol. Biol. 38:127-44
41. Robinson DG, Oliviusson P, Hinz G. 2005. Protein sorting to the storage vacuoles of plants: A critical appraisal. Traffic 6:615-25
42. Takaiwa F. 2013. Update on the use of transgenic rice seeds in oral immunotherapy. Immunotherapy 5:301-12
43. Hood E, Cramer C, MedranoG, Xu J. 2012. Protein targeting: strategic planning for optimizing protein products through plant biotechnology. In Plant Biotechnology and Agriculture, ed.AArie,MHPaul, pp. 35-54. San Diego, CA: Academic
44. Llop-Tous I, Ortiz M, Torrent M, Ludevid MD. 2011. The expression of a xylanase targeted to ERprotein bodies provides a simple strategy to produce active insoluble enzyme polymers in tobacco plants. PLOS ONE 6:e19474
45. Ma JK, Drossard J, Lewis D, Altmann F, Boyle J, et al. 2015. Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. Plant Biotechnol. J. 13:1106-20
46. Wilken LR,Nikolov ZL. 2012. Recovery and purification of plant-made recombinant proteins. Biotechnol. Adv. 30:419-33
47. Buyel JF, Twyman RM, Fischer R. 2015. Extraction and downstream processing of plant-derived recombinant proteins. Biotechnol. Adv. 33:902-13
48. Tuse D, Tu T, McDonald KA. 2014. Manufacturing economics of plant-made biologics: case studies in therapeutic and industrial enzymes. Biomed. Res. Int. 2014:256135
49. Ou J, Guo Z, Shi J, Wang X, Liu J, et al. 2014. Transgenic rice endosperm as a bioreactor for molecular pharming. Plant Cell Rep. 33:585-94
50. Walwyn DR, Huddy SM, Rybicki EP. 2014. Techno-economic analysis of horseradish peroxidase production using a transient expression system in Nicotiana benthamiana. Appl. Biochem. Biotechnol. 175:841-54
51. Buyel JF, Kaever T, Buyel JJ, Fischer R. 2013. Predictive models for the accumulation of a fluorescent marker protein in tobacco leaves according to the promoter/5-UTR combination. Biotechnol. Bioeng. 110:471-82
52. Hood EE, Kusnadi A, Nikolov Z, Howard JA. 1999. Molecular farming of industrial proteins from transgenic maize. Adv. Exp. Med. Biol. 464:127-47
53. Witcher D, Hood E, Peterson D, Bailey M, Bond D, et al. 1998. Commercial production of β-glucuronidase (GUS): A model system for the production of proteins in plants. Mol. Breeding 4:301-12
54. Howard JA, Hood E. 2005. Bioindustrial and biopharmaceutical products produced in plants. In Advances in Agronomy, Vol. 85, ed. D Sparks, pp. 91-124. San Diego, CA: Academic
55. Loos R, Carvalho R, Antonio DC, Comero S, Locoro G, et al. 2013. EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents. Water Res. 47:6475-87
56. Creminon C, Taran F. 2015. Enzyme immunoassays as screening tools for catalysts and reaction discovery. Chem. Commun. 51:7996-8009
57. Collins KD, Gensch T, Glorius F. 2014. Contemporary screening approaches to reaction discovery and development. Nat. Chem. 6:859-71
58. De Meyer T, Muyldermans S, Depicker A. 2014. Nanobody-based products as research and diagnostic tools. Trends Biotechnol. 32:263-70
59. Geering B, FusseneggerM. 2015. Synthetic immunology:modulating the human immune system. Trends Biotechnol. 33:65-79
60. Skerra A. 2007. Alternative non-antibody scaffolds for molecular recognition. Curr. Opin. Biotechnol. 18:295-304
61. Richter A, Eggenstein E, Skerra A. 2014. Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins. FEBS Lett. 588:213-18
62. Schiefner A, Skerra A. 2015. Themenagerie of human lipocalins: A natural protein scaffold formolecular recognition of physiological compounds. Acc. Chem. Res. 48:976-85
63. Justino CIL, Duarte AC, Rocha-Santos TAP. 2015. Analytical applications of affibodies. Trac-Trends Anal. Chem. 65:73-82
64. Robinson MP, Ke N, Lobstein J, Peterson C, Szkodny A, et al. 2015. Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria. Nat. Commun. 6:8072
65. Orzaez D, Granell A, Blazquez MA. 2009. Manufacturing antibodies in the plant cell. Biotechnol. J. 4:1712-24
66. Julve JM, Gandia A, Fernandez-del-Carmen A, Sarrion-Perdigones A, Castelijns B, et al. 2013. A coatindependent superinfection exclusion rapidly imposed in Nicotiana benthamiana cells by tobacco mosaic virus is not prevented by depletion of the movement protein. Plant Mol. Biol. 81:553-64
67. Pujol M, Ramirez NI, Ayala M, Gavilondo JV, Valdes R, et al. 2005. An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification. Vaccine 23:1833-37
68. Ritala A, Leelavathi S, Oksman-Caldentey KM, Reddy VS, LaukkanenML. 2014. Recombinant barleyproduced antibody for detection and immunoprecipitation of the major bovine milk allergen, betalactoglobulin. Transgenic Res. 23:477-87
69. Hood E, Howard J. 2014. Commercial plant-produced recombinant avidin. In Commercial Plant-Produced Recombinant Protein Products: Case Studies, ed. JA Howard, EE Hood, pp. 15-25. Berlin: Springer
70. Neurath H, Walsh KA. 1976. Role of proteolytic enzymes in biological regulation (a review). PNAS 73:3825-32
71. Merten OW. 2002. Virus contaminations of cell cultures-biotechnological view. Cytotechnology 39:91-116
72. Yee L, Blanch HW. 1993. Recombinant trypsin production in high cell density fed-batch cultures in Escherichia coli. Biotechnol. Bioeng. 41:781-90
73. Mattanovich D, KatingerH,Hohenblum H, Naschberger S,Weik R. 2008. Method for the manufacture of recombinant trypsin. US Patent No. 20030157634 A1
74. Muller R, Glaser S, Geipel F, Thalhofer JP, Rexer B, et al. 2010. Method for producing recombinant trypsin. US Patent No. 20080064084 A1
75. Hanquier J, Sorlet Y, Desplancq D, BarocheL,EbtingerM, et al. 2003.Asinglemutation in the activation site of bovine trypsinogen enhances its accumulation in the fermentation broth of the yeast Pichia pastoris. Appl. Environ. Microbiol. 69:1108-13
76. Woodard SL, Mayor JM, Bailey MR, Barker DK, Love RT, et al. 2003. Maize (Zea mays)-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants. Biotechnol. Appl. Biochem. 38:123-30
77. ZhangH,Huang RY, Jalili PR, Irungu JW, Nicol GR, et al. 2010. Improved mass spectrometric characterization of protein glycosylation reveals unusual glycosylation of maize-derived bovine trypsin. Anal. Chem. 82:10095-101
78. Krishnan A, Woodard S. 2014. TryZeanTM: an animal-free alternative to bovine trypsin. See Ref. 69, pp. 43-63
79. Kim NS, YuHY, ChungND, Kwon TH, YangMS. 2014. High-level production of recombinant trypsin in transgenic rice cell culture through utilization of an alternative carbon source and recycling system. Enzyme Microb. Technol. 63:21-27
80. Bornke F, Broer I. 2010. Tailoring plant metabolism for the production of novel polymers and platform chemicals. Curr. Opin. Plant Biol. 13:354-62
81. Canty EG, KadlerKE. 2005. Procollagen trafficking, processing and fibrillogenesis. J. Cell Sci. 118:1341-53
82. Scheller J, Guhrs KH, Grosse F, Conrad U. 2001. Production of spider silk proteins in tobacco and potato. Nat. Biotechnol. 19:573-77
83. Hauptmann V, Menzel M, Weichert N, Reimers K, Spohn U, Conrad U. 2015. In planta production of ELPylated spidroin-based proteins results in non-cytotoxic biopolymers. BMC Biotechnol. 15:9
84. Weichert N, Hauptmann V, Menzel M, Schallau K, Gunkel P, et al. 2014. Transglutamination allows production and characterization of native-sized ELPylated spider silk proteins from transgenic plants. Plant Biotechnol. J. 12:265-75
85. Bhavsar K, Khire JM. 2014. Current research and future perspectives of phytase bioprocessing. RSC Adv. 4:26677-91
86. Gupta RK, Gangoliya SS, Singh NK. 2015. Reduction of phytic acid and enhancement of bioavailable micronutrients in food grains. J. Food Sci. Technol. 52:676-84
87. Xu X, Zhang Y, Meng Q, Meng K, Zhang W, et al. 2013. Overexpression of a fungal beta-mannanase from Bispora sp. MEY-1 in maize seeds and enzyme characterization. PLOS ONE 8:e56146
88. Lv JN, Chen YQ, Guo XJ, Piao XS, Cao YH, Dong B. 2013. Effects of supplementation of betamannanase in corn-soybean meal diets on performance and nutrient digestibility in growing pigs. Asian-Australas. J. Anim. Sci. 26:579-87
89. Zhang Y, Xu X, Zhou X, Chen R, Yang P, et al. 2013. Overexpression of an acidic endo-beta-1,3-1,4-glucanase in transgenic maize seed for direct utilization in animal feed. PLOS ONE 8:e81993
90. Ranum P, Pena-Rosas JP, Garcia-Casal MN. 2014. Global maize production, utilization, and consumption. Ann. N. Y. Acad. Sci. 1312:105-12
91. Hood E, Requesens D. 2014. Commercial plant-produced recombinant cellulases for biomass conversion. See Ref. 69, pp. 231-46
92. Li Q, Song J, Peng S, Wang JP, Qu GZ, et al. 2014. Plant biotechnology for lignocellulosic biofuel production. Plant Biotechnol. J. 12:1174-92
93. Zhang D, VanFossen A, Pagano R, Johnson J, Parker M, et al. 2011. Consolidated pretreatment and hydrolysis of plant biomass expressing cell wall degrading enzymes. BioEnergy Res. 4:276-86
94. Shen B, Sun X, Zuo X, Shilling T, Apgar J, et al. 2012. Engineering a thermoregulated intein-modified xylanase into maize for consolidated lignocellulosic biomass processing. Nat. Biotechnol. 30:1131-36
95. Blaylock MJ, Ferguson BW, Lee DA. 2012. Energy crops for improved biofuel feedstocks. US Patent No. 20070250961 A1
96. Hood EE, Love R, Lane J, Bray J, Clough R, et al. 2007. Subcellular targeting is a key condition for high-level accumulation of cellulase protein in transgenic maize seed. Plant Biotechnol. J. 5:709-19
97. Urbanchuk JM, Kowalski DJ, Dale B, Kim S. 2009. Corn amylase: improving the efficiency and environmental footprint of corn to ethanol through plant biotechnology. AgBioForum 12:149-54
98. van der Maarel MJ, van der Veen B, Uitdehaag JC, Leemhuis H, Dijkhuizen L. 2002. Properties and applications of starch-converting enzymes of the alpha-amylase family. J. Biotechnol. 94:137-55
99. Widsten P, Kandelbauer A. 2008. Laccase applications in the forest products industry: A review. Enzyme Microb. Technol. 42:293-307
100. Hood EE, BaileyMR, Beifuss K,Magallanes-Lundback M, Horn ME, et al. 2003. Criteria for high-level expression of a fungal laccase gene in transgenic maize. Plant Biotechnol. J. 1:129-40
101. BaileyMR, Woodard SL, Callaway E, BeifussK,Magallanes-LundbackM,et al. 2004. Improved recovery of active recombinant laccase from maize seed. Appl. Microbiol. Biotechnol. 63:390-97
102. Juturu V,WuJC. 2012. Microbial xylanases: engineering, production and industrial applications. Biotechnol. Adv. 30:1219-27
103. Sharma A, Thakur VV, Shrivastava A, Jain RK, Mathur RM, et al. 2014. Xylanase and laccase based enzymatic kraft pulp bleaching reduces adsorbable organic halogen (AOX) in bleach effluents: A pilot scale study. Bioresour. Technol. 169:96-102
104. Singh Arora D, Kumar Sharma R. 2010. Ligninolytic fungal laccases and their biotechnological applications. Appl. Biochem. Biotechnol. 160:1760-88
105. Wang GD, Li QJ, Luo B, Chen XY. 2004. Ex planta phytoremediation of trichlorophenol and phenolic allelochemicals via an engineered secretory laccase. Nat. Biotechnol. 22:893-97
106. Singh R, Cabrera ML, Radcliffe DE, Zhang H, Huang Q. 2015. Laccase mediated transformation of 17beta-estradiol in soil. Environ. Pollut. 197:28-35
107. Li S, Yang X, Yang S, Zhu M, Wang X. 2012. Technology prospecting on enzymes: Application, marketing and engineering. Comput. Struct. Biotechnol. J. 2:1-11
108. Howard J, Nikolov Z, Hood E. 2011. Enzyme production systems for biomass conversion. In Plant Biomass Conversion, ed. E Hood, P Nelson, R Powell, pp. 227-53. Hoboken, NJ: Wiley-Blackwell
109. Ranganathan SV, Narasimhan SL, Muthukumar K. 2008. An overview of enzymatic production of biodiesel. Bioresour. Technol. 99:3975-81
110. Du W, Li W, Sun T, Chen X, Liu D. 2008. Perspectives for biotechnological production of biodiesel and impacts. Appl. Microbiol. Biotechnol. 79:331-37
111. Yang B, Wang Y-H, Yang J-G. 2006. Optimization of enzymatic degumming process for rapeseed oil. J. Am. Oil Chem. Soc. 83:653-58
112. Bussamra BC, Freitas S,Costa AC. 2015. Improvement on sugar cane bagasse hydrolysis using enzymatic mixture designed cocktail. Bioresour. Technol. 187:173-81
113. Clough RC, Pappu K, Thompson K, Beifuss K, Lane J, et al. 2006. Manganese peroxidase from the white-rot fungus Phanerochaete chrysosporium is enzymatically active and accumulates to high levels in transgenic maize seed. Plant Biotechnol. J. 4:53-62
114. Hayes TL, Zimmerman N, Hackle A. 2014. World enzymes: industry study with forecasts for 2011 & 2016. Rep. 2229, Freedonia Group, Cleveland, OH
115. Hood EE, Love R, Lane J, Bray J, Clough R, et al. 2007. Subcellular targeting is a key condition for high-level accumulation of cellulase protein in transgenic maize seed. Plant Biotechnol. J. 5:709-19
116. Hood EE, Devaiah SP, Fake G, Egelkrout E, Teoh K, et al. 2012. Manipulating corn germplasm to increase recombinant protein accumulation. Plant Biotechnol. J. 10:20-30
117. Hood NC, Hood KR,Woodard SL, Devaiah SP, Jeoh T, et al. 2014. Purification and characterization of recombinant cel7a from maize seed. Appl. Biochem. Biotechnol. 174:2864-74
118. Sparrow P, Broer I, Hood EE, Eversole K, Hartung F, Schiemann J. 2013. Risk assessment and regulation of molecular farming-a comparison between Europe and US. Curr. Pharm. Des. 19:5513-30
119. Bock R. 2015. Engineering plastid genomes: methods, tools, and applications in basic research and biotechnology. Annu. Rev. Plant Biol. 66:211-41
120. Whaley KJ, Hiatt A, Zeitlin L. 2011. Emerging antibody products and Nicotiana manufacturing. Hum. Vaccines 7:349-56
121. D'Aoust MA, Couture MM, Charland N, Trepanier S, Landry N, et al. 2010. The production of hemagglutinin-based virus-like particles in plants: A rapid, efficient and safe response to pandemic influenza. Plant Biotechnol. J. 8:607-19
122. Vezina LP, Faye L, Lerouge P, D'Aoust MA, Marquet-Blouin E, et al. 2009. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol. J. 7:442-55
123. Yusibov V, Rabindran S, Commandeur U, Twyman RM, Fischer R. 2006. The potential of plant virus vectors for vaccine production. Drugs Res. Dev. 7:203-17
124. Yusibov V, Rabindran S. 2008. Recent progress in the development of plant derived vaccines. Expert Rev. Vaccines 7:1173-83
125. Yusibov V, Streatfield SJ, Kushnir N, Roy G, Padmanaban A. 2013. Hybrid viral vectors for vaccine and antibody production in plants. Curr. Pharm. Des. 19:5574-86
126. CanizaresMC,Lomonossoff GP,NicholsonL. 2005. Development of cowpeamosaic virus-based vectors for the production of vaccines in plants. Expert Rev. Vaccines 4:687-97
127. Lico C, Chen Q, Santi L. 2008. Viral vectors for production of recombinant proteins in plants. J. Cell Physiol. 216:366-77
128. Sainsbury F, Lavoie PO, D'Aoust MA, Vezina LP, Lomonossoff GP. 2008. Expression of multiple proteins using full-length and deleted versions of cowpea mosaic virus RNA-2. Plant Biotechnol. J. 6:82-92
129. Marillonnet S, Thoeringer C, Kandzia R, Klimyuk V, Gleba Y. 2005. Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat. Biotechnol. 23:718-23
130. Gleba Y, Klimyuk V, Marillonnet S. 2005. Magnifection-a new platform for expressing recombinant vaccines in plants. Vaccine 23:2042-48
131. Gleba Y, Klimyuk V, Marillonnet S. 2007. Viral vectors for the expression of proteins in plants. Curr. Opin. Biotechnol. 18:134-41
132. Sainsbury F, Lomonossoff GP. 2008. Extremely high-level and rapid transient protein production in plants without the use of viral replication. Plant Physiol. 148:1212-18
133. Phan HT, Hause B, Hause G, Arcalis E, Stöger E, et al. 2014. Influence of elastin-like polypeptide and hydrophobin on recombinant hemagglutinin accumulations in transgenic tobacco plants. PLOS ONE 9:e99347
134. Reuter LJ, BaileyMJ, Joensuu JJ, Ritala A. 2014. Scale-up of hydrophobin-assisted recombinant protein production in tobacco BY-2 suspension cells. Plant Biotechnol. J. 12:402-10
135. Gutierrez SP, Saberianfar R, Kohalmi SE, Menassa R. 2013. Protein body formation in stable transgenic tobacco expressing elastin-like polypeptide and hydrophobin fusion proteins. BMC Biotechnol. 13:40
136. van Rooijen GJ, Moloney MM. 1995. Plant seed oil-bodies as carriers for foreign proteins. Biotechnology 13:72-77
137. Nykiforuk CL, Boothe JG, Murray EW, Keon RG, Goren HJ, et al. 2006. Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnol. J. 4:77-85
138. Nykiforuk CL, Boothe JG. 2012. Transgenic expression of therapeutic proteins in Arabidopsis thaliana seed. Methods Mol. Biol. 899:239-64
139. Anfossi L, Baggiani C, Giovannoli C, D'Arco G, Giraudi G. 2013. Lateral-flow immunoassays for mycotoxins and phycotoxins: A review. Anal. Bioanal. Chem. 405:467-80
140. Taranova NA, Berlina AN, Zherdev AV, Dzantiev BB. 2015. 'Traffic light' immunochromatographic test based on multicolor quantum dots for the simultaneous detection of several antibiotics in milk. Biosens. Bioelectron. 63:255-61
141. Cho IH, Radadia AD, Farrokhzad K, Ximenes E, Bae E, et al. 2014. Nano/micro and spectroscopic approaches to food pathogen detection. Annu. Rev. Anal. Chem. 7:65-88
142. Warriner K, Reddy SM, Namvar A, Neethirajan S. 2014. Developments in nanoparticles for use in biosensors to assess food safety and quality. Trends Food Sci. Technol. 40:183-99
143. Knopp D, Tang D, Niessner R. 2009. Review: bioanalytical applications of biomolecule-functionalized nanometer-sized doped silica particles. Anal. Chim. Acta 647:14-30